Discordant prolongation of the refractory period and repolarization time by a class III agent, E4031, in the healing phase of myocardial infarction

Seiji Takatsuki, Hideo Mitamura, Koichiro Sueyoshi, Hideaki Kanki, Izumi Furuno, Satoshi Ogawa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Susceptibility to reentrant tachyarrhythmias and the antiarrhythmic efficacy of class III agents are related more to the duration of the refractory period (ERP) than to the repolarization time (RT). We measured both ERP and RT in a canine model of healing myocardial infarction, and evaluated the effect of a class III agent (E4031) on these parameters and on the inducibility of ventricular tachyarrhythmias. ERP and RT on the unipolar electrogram were measured at several cycle lengths in the normal (NZ) and infarct zones (IZ), respectively, in 10 canine myocardial infarction models and extrastimulation was used to induce ventricular arrhythmias. Measurements were repeated after E4031 administration. At baseline, both ERP and RT were significantly longer in IZ than in NZ with ERP/RT ratio also higher in IZ. This ratio tended to increase at longer cycle lengths. E4031 increased ERP and RT both in NZ and IZ at all cycle lengths, but increased the ERP/RT ratio predominantly in IZ. E4031 prevented induction of sustained VT or VF, which was inducible in 3 out of 10 dogs at baseline, although it facilitated induction of VF in 1 dog wth no baseline arrhythmia. By increasing the ERP/RT ratio, class III drugs may shorten the relative refractory period in IZ at the expense of a greater ERP difference created between NZ and IZ.

Original languageEnglish
Pages (from-to)687-697
Number of pages11
JournalJapanese Heart Journal
Volume39
Issue number5
Publication statusPublished - 1998 Sep

Fingerprint

Myocardial Infarction
Tachycardia
Canidae
Cardiac Arrhythmias
Dogs
Pharmaceutical Preparations

Keywords

  • Canine
  • Class III antiarrhythmic agent
  • Myocardial infarction
  • Refractory period
  • Repolarization
  • Ventricular arrhythmia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Discordant prolongation of the refractory period and repolarization time by a class III agent, E4031, in the healing phase of myocardial infarction. / Takatsuki, Seiji; Mitamura, Hideo; Sueyoshi, Koichiro; Kanki, Hideaki; Furuno, Izumi; Ogawa, Satoshi.

In: Japanese Heart Journal, Vol. 39, No. 5, 09.1998, p. 687-697.

Research output: Contribution to journalArticle

Takatsuki, Seiji ; Mitamura, Hideo ; Sueyoshi, Koichiro ; Kanki, Hideaki ; Furuno, Izumi ; Ogawa, Satoshi. / Discordant prolongation of the refractory period and repolarization time by a class III agent, E4031, in the healing phase of myocardial infarction. In: Japanese Heart Journal. 1998 ; Vol. 39, No. 5. pp. 687-697.
@article{06957f9787af472cb831fb645706a2d1,
title = "Discordant prolongation of the refractory period and repolarization time by a class III agent, E4031, in the healing phase of myocardial infarction",
abstract = "Susceptibility to reentrant tachyarrhythmias and the antiarrhythmic efficacy of class III agents are related more to the duration of the refractory period (ERP) than to the repolarization time (RT). We measured both ERP and RT in a canine model of healing myocardial infarction, and evaluated the effect of a class III agent (E4031) on these parameters and on the inducibility of ventricular tachyarrhythmias. ERP and RT on the unipolar electrogram were measured at several cycle lengths in the normal (NZ) and infarct zones (IZ), respectively, in 10 canine myocardial infarction models and extrastimulation was used to induce ventricular arrhythmias. Measurements were repeated after E4031 administration. At baseline, both ERP and RT were significantly longer in IZ than in NZ with ERP/RT ratio also higher in IZ. This ratio tended to increase at longer cycle lengths. E4031 increased ERP and RT both in NZ and IZ at all cycle lengths, but increased the ERP/RT ratio predominantly in IZ. E4031 prevented induction of sustained VT or VF, which was inducible in 3 out of 10 dogs at baseline, although it facilitated induction of VF in 1 dog wth no baseline arrhythmia. By increasing the ERP/RT ratio, class III drugs may shorten the relative refractory period in IZ at the expense of a greater ERP difference created between NZ and IZ.",
keywords = "Canine, Class III antiarrhythmic agent, Myocardial infarction, Refractory period, Repolarization, Ventricular arrhythmia",
author = "Seiji Takatsuki and Hideo Mitamura and Koichiro Sueyoshi and Hideaki Kanki and Izumi Furuno and Satoshi Ogawa",
year = "1998",
month = "9",
language = "English",
volume = "39",
pages = "687--697",
journal = "International Heart Journal",
issn = "1349-2365",
publisher = "International Heart Journal Association",
number = "5",

}

TY - JOUR

T1 - Discordant prolongation of the refractory period and repolarization time by a class III agent, E4031, in the healing phase of myocardial infarction

AU - Takatsuki, Seiji

AU - Mitamura, Hideo

AU - Sueyoshi, Koichiro

AU - Kanki, Hideaki

AU - Furuno, Izumi

AU - Ogawa, Satoshi

PY - 1998/9

Y1 - 1998/9

N2 - Susceptibility to reentrant tachyarrhythmias and the antiarrhythmic efficacy of class III agents are related more to the duration of the refractory period (ERP) than to the repolarization time (RT). We measured both ERP and RT in a canine model of healing myocardial infarction, and evaluated the effect of a class III agent (E4031) on these parameters and on the inducibility of ventricular tachyarrhythmias. ERP and RT on the unipolar electrogram were measured at several cycle lengths in the normal (NZ) and infarct zones (IZ), respectively, in 10 canine myocardial infarction models and extrastimulation was used to induce ventricular arrhythmias. Measurements were repeated after E4031 administration. At baseline, both ERP and RT were significantly longer in IZ than in NZ with ERP/RT ratio also higher in IZ. This ratio tended to increase at longer cycle lengths. E4031 increased ERP and RT both in NZ and IZ at all cycle lengths, but increased the ERP/RT ratio predominantly in IZ. E4031 prevented induction of sustained VT or VF, which was inducible in 3 out of 10 dogs at baseline, although it facilitated induction of VF in 1 dog wth no baseline arrhythmia. By increasing the ERP/RT ratio, class III drugs may shorten the relative refractory period in IZ at the expense of a greater ERP difference created between NZ and IZ.

AB - Susceptibility to reentrant tachyarrhythmias and the antiarrhythmic efficacy of class III agents are related more to the duration of the refractory period (ERP) than to the repolarization time (RT). We measured both ERP and RT in a canine model of healing myocardial infarction, and evaluated the effect of a class III agent (E4031) on these parameters and on the inducibility of ventricular tachyarrhythmias. ERP and RT on the unipolar electrogram were measured at several cycle lengths in the normal (NZ) and infarct zones (IZ), respectively, in 10 canine myocardial infarction models and extrastimulation was used to induce ventricular arrhythmias. Measurements were repeated after E4031 administration. At baseline, both ERP and RT were significantly longer in IZ than in NZ with ERP/RT ratio also higher in IZ. This ratio tended to increase at longer cycle lengths. E4031 increased ERP and RT both in NZ and IZ at all cycle lengths, but increased the ERP/RT ratio predominantly in IZ. E4031 prevented induction of sustained VT or VF, which was inducible in 3 out of 10 dogs at baseline, although it facilitated induction of VF in 1 dog wth no baseline arrhythmia. By increasing the ERP/RT ratio, class III drugs may shorten the relative refractory period in IZ at the expense of a greater ERP difference created between NZ and IZ.

KW - Canine

KW - Class III antiarrhythmic agent

KW - Myocardial infarction

KW - Refractory period

KW - Repolarization

KW - Ventricular arrhythmia

UR - http://www.scopus.com/inward/record.url?scp=0031796867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031796867&partnerID=8YFLogxK

M3 - Article

C2 - 9926000

AN - SCOPUS:0031796867

VL - 39

SP - 687

EP - 697

JO - International Heart Journal

JF - International Heart Journal

SN - 1349-2365

IS - 5

ER -